Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia

Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia

We investigated the impact of sarcopenia on adjuvant chemotherapy dosing in advanced epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible patients who underwent cytoreductive surgery and adjuvant chemotherapy at a single institution were analyzed. Patients with a ske...

Full description

Bibliographic Details
Main Authors: Rushi Shah, Clarissa Polen-De, Michaela McGree, Angela Fought, Amanika Kumar
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Current Oncology
Subjects:
sarcopenia
adjuvant chemotherapy
advanced epithelial ovarian cancer
relative dose intensity
cytoreductive surgery
overall survival
Online Access:https://www.mdpi.com/1718-7729/30/11/688

Internet

https://www.mdpi.com/1718-7729/30/11/688

Similar Items